Consistent with the results in B-ALL cell lines, the PKC inhibitor GF109203X restored Dex sensitivity in Dex-resistant primary blood and BM samples (Supplementary Fig. 10j). This evidence concerns the gene PRRT2 and acute lymphoblastic leukemia.